Cell and Gene Therapy Manufacturing: Are We There Yet?
Cell and Gene Therapy Manufacturing: Are We There Yet?
Presentation and Panel Discussion
March 30, 2023
Time: 6 pm-8 pm
Bristol-Myers Squibb
3401 Princeton Pike
Lawrence Twp., NJ 08648
Cell and Gene Therapy is becoming an important area of biopharmaceuticals to address fundamental healthcare areas such as oncology, heart disease, hemophilia, and diabetes. The evening will provide attendees with a review of the cell and gene therapy manufacturing trends. Some major concerns of the industry is the scale-up of manufacturing processes from the laboratory and increasing manufacturing capacity to support the expansion of this sector. We will cover general manufacturing approaches, quality and regulatory considerations, facility design and operations and how digitalization can have an impact on manufacturing capabilities.
Robert Lechich from Global OT-IT Quality Services will provide a short presentation and moderate a panel discussion of industry leaders to cover manufacturing, facilities, quality, technical considerations and automation perspectives.
Please join us for what will be an interesting update for all.
Moderator:
- Robert Lechich, Principal Consultant GOTIT Quality Services
Panelists:
- Angelo Bartolomei, Director Manufacturing Science and Technology, CAR-T Process Engineering BMS
- Francesca McBride, Regulatory Compliance SME Jacobs
- Jeffrey Pawar, Sr Director Site Operations Rocket Pharmaceuticals
- John Paul Tomtishen III VP of Operations Cellares
- Jo Anne Valentino Independent Pharmaceutical Quality Consultant
Cost:
-
Members: $75
-
Non-Members: $100
-
Student Members and Chapter Academic Advisor: $10
-
Emerging Leaders: $50
Sponsorships are available:
-
Gold Sponsor: $500 (includes two free tickets to event)
-
Event Sponsor: $300 (includes one free ticket to event)